Sutton Wealth Advisors Inc. Iovance Biotherapeutics, Inc. Transaction History

Sutton Wealth Advisors Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2023	SELL	$9.53 - $13.11 $0 - $0	0 Closed	0 $0
Q2 2022 Nov 07, 2023	SELL	$6.38 - $18.33 $484 - $1,393	-76 Closed	0 $0
Q1 2022 Nov 07, 2023	BUY	$12.38 - $19.1 $940 - $1,451	76 New	76 $1.27 Million
Q4 2021 Nov 07, 2023	SELL	$16.55 - $27.63 $761 - $1,270	-46 Closed	0 $0
Q3 2021 Nov 07, 2023	BUY	$20.35 - $26.63 $936 - $1,224	46 New	46 $1.13 Million

313

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.